Evan S. Kipperman


Evan S. Kipperman
offices New Haven
New York
phone 203-363-7628
view LinkedIn profile


Evan is dedicated to helping growth-stage companies, publicly held middle-market companies, family offices, high-net-worth individuals, private equity firms, and other clients achieve their business goals. A Partner in the firm's Corporate Department and Co-chair of its Emerging Companies and Venture Capital Practice Group, Evan is known for his ability to quickly grasp complex situations, deliver business-minded legal advice, and help clients surmount obstacles.

Evan focuses on corporate finance transactions, mergers and acquisitions, venture capital financing, securities law, licensing arrangements, and general corporate matters, across a broad range of industries that includes software/information technology, life sciences, digital media, financial services, manufacturing, educational technology, consumer products, and food and beverages.

For example, he recently assisted in

  • The $550 million sale of a privately held software company to a private equity buyer.
  • Major acquisitions both for a manufacturer of doors and window frames and for an international consumer electronics company.
  • The $2.2 billion sale of a publicly traded provider of high-bandwidth connectivity.
  • Securing hundreds of millions of dollars in financing for dozens of growth-stage companies.

In addition to handling specific transactions, Evan regularly serves as outside general counsel for privately held companies at various stages of development, ensuring that they are appropriately structured, scalable, and positioned for growth.

An active member of the business and investment community in the heart of the corridor connecting Boston and New York, Evan cultivates a network that includes organizations such as Crossroads Venture Group, Connecticut Technology Council, BioCT, MIT Enterprise Forum, Angel Investor Forum, the Entrepreneurship Foundation, the Refinery, Angel Capital Association, and the Association for Corporate Growth, as well as academic institutions such as Columbia University, New York University, University of Connecticut, and Yale University.

Before joining Wiggin and Dana, Evan was an associate at a prominent New York law firm, where he gained extensive experience advising U. S. and international public and private companies in a wide range of industries, with regard to mergers and acquisitions, securities transactions, and general corporate matters.

Evan received his J.D. from the University of Pennsylvania Law School, where he was a senior editor at the Journal of International Economic Law. He received his B.A. in international relations and political science from the University of Pennsylvania.


Mergers and Acquisitions

Some of Evan's experience includes the representation of:

  • Assa Abloy AB (OMX) in its acquisition of Frameworks Manufacturing Inc., a manufacturer of aluminum doors and window frames
  • AboveNet, Inc. (NYSE), a provider of high-band width connectivity solutions, in connection with its $2.2 billion sale to Zayo Group, LLC
  • HistoRx, Inc., a developer of diagnostic testing to improve physicians' ability to optimize patient outcomes, in its sale by merger to Genoptix, Inc., a subsidiary of Novartis (NYSE)
  • iDevices, LLC, a leading IoT company, in its sale to Hubbell Incorporated (NYSE)
  • Genpact Limited (NYSE) in its acquisition of Jawood Business Process Solutions, L.L.C., a leading provider of business services to the healthcare payer industry
  • a family office based in Greenwich, Connecticut in its acquisitions of a series of agriculture equipment servicers and dealerships
  • Harman International Industries, Incorporated (NYSE) in its acquisition of Yurbuds, a market leader in sports headphones

Venture Capital Transactions

Some of Evan's experience includes the representation of:

  • Amastan Technologies in connection with a $13.85 million preferred equity investment from Anzu Partners, Material Impact, RKS Ventures, KLP Ventures and Launch Capital
  • Decisyon Inc. in connection with a $22 million preferred equity investment led by Catalyst Investors
  • IsoPlexis Corporation in connection with a $13.5 million preferred equity investment led by Spring Mountain Capital
  • New Haven Pharmaceuticals in connection with securing a Venture Loan Facility from Horizon Technology Finance
  • an Italian software company in connection with securing a $5 million venture capital loan facility
  • Point72 Ventures in connection with its role as an investor in numerous technology businesses

Other Representative Transactions

  • Representation of Connecticut United for Research Excellence (CURE) in connection with securing financing from the Connecticut Department of Economic and Community Development (DECD)
  • Representation of SurgiQuest, Inc., a venture backed medical device company, in securing $20 million in debt financing from MidCap Financial
  • Advised board of directors of a cloud computing company in connection with the liquidation of the company's assets
  • Representation of Connecticut based life sciences company in the negotiation of an exclusive license of its principal technology from Yale University
  • Formation of and preparation of organizational documentation and shareholders' agreements for international e-commerce platform
  • Representation of NASDAQ listed medical device company in the negotiation of key product development and supply agreement
  • Representation of Swedish pharmaceutical company in the negotiation of a collaboration agreement with European university

offices New Haven
New York
phone 203-363-7628
view LinkedIn profile



  • University of Pennsylvania Law School, J.D., 2005
  • University of Pennsylvania, B.A., 2001


  • Connecticut
  • New York

© 1998-2018 Wiggin and Dana LLP   |   Disclaimer Notice   |   Attorney Advertisement   |   Privacy Policy   |   Contact
© 1998-2018 Wiggin and Dana LLP